Thieno[2,3-b-indole derivatives and their use for treating central nervous system diseases related to the metabotropic glutamate receptor system
US5536721A · kind A · utility
13Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 1995 |
| Grant date | Jul 16, 1996 |
| Priority date | — |
| Expiry date | Mar 14, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D209/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to therapeutically active heterocyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system related to the metabotropic glutamate receptor system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.